Brain tumors remain one of the most challenging forms of cancer despite continuing advances in diagnosis and treatment. Improved therapies will require a greatly-improved understanding of how specific genetic alterations can lead to the development and growth of brain tumors. We are seeking to develop an improved model system in which normal human astrocytes can be transformed through the introduction of defined genetic alterations to analyze the biologic alterations caused by these changes. An analysis of the genetic alterations frequently found in human brain tumor samples allows for the development of a set of targets that are likely required for alteration in the transformation of the normal precursor cell for astrocytomas, the astrocyte. Our hypothesis is that the transformation of normal human astrocytes into gliomas can be modeled by a restricted set of minimal required genetic alterations and that targeting of these pathways will permit the development of therapies useful in a broad range of gliomas. We plan to use the previously established system of amphotropic retroviruses with SV-40 large T antigen, hTERT, and HrasV12G to transform human astrocytes.
Our Specific Aims i nclude to determine: 1) if large T antigen, hTERT, and HrasVl2G are sufficient to transform human astrocytes and measure genomic instability and gene expression changes, 2) the relative importance of different rasactivated pathways in astrocyte transformation, 3) if a constitutively active EGF receptor mutant is sufficient to replace activated ras in transforming astrocytes, 4) the effect of TGF beta expression on tumor growth and development, 5) if the loss of the tumor suppressor gene Pten is sufficient to activate ras pathways to permit transformation, and 6) if pathway-specific inhibitors can prevent astrocyte transformation and tumor growth.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Clinical Investigator Award (CIA) (K08)
Project #
2K08NS002055-04
Application #
6344393
Study Section
NST-2 Subcommittee (NST)
Program Officer
Jacobs, Tom P
Project Start
1998-07-01
Project End
2003-06-30
Budget Start
2001-07-20
Budget End
2002-06-30
Support Year
4
Fiscal Year
2001
Total Cost
$125,334
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Rich, Jeremy N (2003) The role of transforming growth factor-beta in primary brain tumors. Front Biosci 8:e245-60
Rich, Jeremy N; Shi, Qing; Hjelmeland, Mark et al. (2003) Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J Biol Chem 278:15951-7
Rich, J N; Guo, C; McLendon, R E et al. (2001) A genetically tractable model of human glioma formation. Cancer Res 61:3556-60